{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:56:33Z","timestamp":1788274593781,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,12,30]],"date-time":"2013-12-30T00:00:00Z","timestamp":1388361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"Alzheimer's Disease Neuroimaging Initiative (ADNI)"},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001316","name":"Abbott","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100002565","name":"Alzheimer's Drug Discovery Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100002565","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007611","name":"Amorfix Life Sciences Ltd.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007611","id-type":"DOI","asserted-by":"crossref"}]},{"name":"AstraZeneca"},{"DOI":"10.13039\/501100000801","name":"Bayer HealthCare","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000801","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007742","name":"BioClinica, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007742","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Biogen Idec Inc."},{"name":"Bristol-Myers Squibb Company"},{"name":"Eisai Inc."},{"name":"Elan Pharmaceuticals Inc."},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004337","name":"F. Hoffmann-La Roche Ltd","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004328","name":"Genentech, Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Innogenetics, N.V."},{"name":"IXICO Ltd."},{"name":"Janssen Alzheimer Immunotherapy Research & Development, LLC."},{"name":"Johnson & Johnson Pharmaceutical Research & Development LLC."},{"name":"Medpace, Inc."},{"DOI":"10.13039\/100004334","name":"Merck & Co., Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Meso Scale Diagnostics, LLC."},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Inc.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Synarc Inc."},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["P30 AG010129"],"award-info":[{"award-number":["P30 AG010129"]}]},{"name":"NIH","award":["K01 AG030514"],"award-info":[{"award-number":["K01 AG030514"]}]},{"name":"Easton Consortium for Alzheimer's Drug Discovery and Biomarker Development","award":["NIA R01 AG040770"],"award-info":[{"award-number":["NIA R01 AG040770"]}]},{"name":"Easton Consortium for Alzheimer's Drug Discovery and Biomarker Development","award":["NIA P50 AG16570"],"award-info":[{"award-number":["NIA P50 AG16570"]}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"crossref","award":["R01 MH097268"],"award-info":[{"award-number":["R01 MH097268"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIA","award":["R01 AG040060"],"award-info":[{"award-number":["R01 AG040060"]}]},{"name":"UCLA Dissertation Year Fellowship"},{"name":"UCLA Medical Scientist Training Program"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Easton Consortium for Alzheimer's Drug Development and Biomarker Discovery"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Alexander Family Alzheimer's Disease Research Professorship of the Mayo Foundation"},{"name":"MJFox Foundation for Parkinson's Research"},{"name":"NeuroVigil, Inc."},{"name":"CHRU-Hopital Roger Salengro"},{"DOI":"10.13039\/501100004830","name":"Siemens","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004830","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006388","name":"Geneva University Hospitals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006388","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004312","name":"Lilly","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"crossref"}]},{"name":"San Diego \u2014 ADNI"},{"name":"Paris University"},{"name":"Institut Catala de Neurociencies Aplicades"},{"name":"University of New Mexico School of Medicine"},{"DOI":"10.13039\/501100014382","name":"Ipsen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CTAD (Clinical Trials on Alzheimer's Disease)"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"name":"ADPD meeting"},{"name":"Paul Sabatier University"},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tohoku University"},{"name":"Fundacio ACE and Travel eDreams, Inc."}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1016\/j.nicl.2013.12.012","type":"journal-article","created":{"date-parts":[[2014,1,4]],"date-time":"2014-01-04T03:18:24Z","timestamp":1388805504000},"page":"461-472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"special_numbering":"C","title":["ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease"],"prefix":"10.1016","volume":"4","author":[{"given":"Liana G.","family":"Apostolova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy S.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omid","family":"Kohannim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Avila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Elashoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Clifford R.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Q.","family":"Trojanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nicl.2013.12.012_bb0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archneur.58.3.373","article-title":"Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice","volume":"58","author":"Andreasen","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nicl.2013.12.012_bb0290","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.neuropsychologia.2007.10.026","article-title":"Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment","volume":"46","author":"Apostolova","year":"2008","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.nicl.2013.12.012_bb0025","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/archneur.63.5.693","article-title":"Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps","volume":"63","author":"Apostolova","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nicl.2013.12.012_bb0030","article-title":"Subregional hippocampal atrophy predicts future decline to Alzheimer's dementia in cognitively normal subjects","author":"Apostolova","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2013.12.012_bb0035","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/hbm.20905","article-title":"3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI","volume":"31","author":"Apostolova","year":"2010","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.nicl.2013.12.012_bb0075","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.neurobiolaging.2010.05.003","article-title":"3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects","volume":"31","author":"Apostolova","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2013.12.012_bb0295","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.neurobiolaging.2008.08.008","article-title":"Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal","volume":"31","author":"Apostolova","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2013.12.012_bb0255","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.neuroimage.2009.12.125","article-title":"Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects","volume":"51","author":"Apostolova","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2013.12.012_bb0080","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(03)00530-1","article-title":"CSF markers for incipient Alzheimer's disease","volume":"2","author":"Blennow","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nicl.2013.12.012_bb0090","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF02815140","article-title":"Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?","volume":"26","author":"Blennow","year":"1995","journal-title":"Mol. Chem. Neuropathol."},{"key":"10.1016\/j.nicl.2013.12.012_bb0060","first-page":"205","article-title":"Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer disease","volume":"6","author":"Bobinski","year":"1995","journal-title":"Dementia"},{"key":"10.1016\/j.nicl.2013.12.012_bb0055","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00005072-199704000-00010","article-title":"Relationships between regional neuronal loss and neurofibrillary changes in the hippocampal formation and duration and severity of Alzheimer disease","volume":"56","author":"Bobinski","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nicl.2013.12.012_bb0135","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.neurobiolaging.2007.08.010","article-title":"Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment","volume":"30","author":"Brys","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2013.12.012_bb0115","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1212\/WNL.59.4.627","article-title":"CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects","volume":"59","author":"Buerger","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2013.12.012_bb0110","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1212\/01.wnl.0000183284.92920.f2","article-title":"Phosphorylated tau predicts rate of cognitive decline in MCI subjects: a comparative CSF study","volume":"65","author":"Buerger","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2013.12.012_bb0095","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/archneur.60.12.1696","article-title":"Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?","volume":"60","author":"Clark","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nicl.2013.12.012_bb0225","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00004728-199403000-00005","article-title":"Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space","volume":"18","author":"Collins","year":"1994","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.nicl.2013.12.012_bb0300","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1212\/WNL.55.11.1636","article-title":"Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer type","volume":"55","author":"Csernansky","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2013.12.012_bb0155","doi-asserted-by":"crossref","first-page":"e21896","DOI":"10.1371\/journal.pone.0021896","article-title":"Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors","volume":"6","author":"Cui","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.nicl.2013.12.012_bb0170","doi-asserted-by":"crossref","first-page":"e2319","DOI":"10.1016\/j.neurobiolaging.2010.05.023","article-title":"Prediction of MCI to AD conversion, via MRI, CSF biomarkers, and pattern classification","volume":"32","author":"Davatzikos","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2013.12.012_bb0125","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neurobiolaging.2005.07.003","article-title":"Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment","volume":"27","author":"de Leon","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2013.12.012_bb0040","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/(SICI)1098-1063(2000)10:2<136::AID-HIPO2>3.0.CO;2-J","article-title":"Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer's disease","volume":"10","author":"de Toledo-Morrell","year":"2000","journal-title":"Hippocampus"},{"key":"10.1016\/j.nicl.2013.12.012_bb0270","first-page":"e1071","article-title":"e1071: Misc Functions of the Department of Statistics","author":"Dimitriadou","year":"2006"},{"key":"10.1016\/j.nicl.2013.12.012_bb0165","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.neurobiolaging.2010.10.019","article-title":"Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance","volume":"33","author":"Ewers","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2013.12.012_bb0045","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1093\/brain\/awh559","article-title":"Implicit memory and Alzheimer's disease neuropathology","volume":"128","author":"Fleischman","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2013.12.012_bb0230","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/jcss.1997.1504","article-title":"A decision-theoretic generalization of online learning and an application to boosting","volume":"55","author":"Freund","year":"1997","journal-title":"J. Comp. Syst. Sci."},{"key":"10.1016\/j.nicl.2013.12.012_bb0130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jalz.2009.04.1235","article-title":"Markers of Alzheimer's disease in a population attending a memory clinic","volume":"5","author":"Frisoni","year":"2009","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nicl.2013.12.012_bb0100","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archneur.55.7.937","article-title":"High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype","volume":"55","author":"Galasko","year":"1998","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nicl.2013.12.012_bb0205","series-title":"ISMRM 14th Scientific Meeting and Exhibition","article-title":"Validation testing of the MRI calibration phantom for the Alzheimer's Disease Neuroimaging Initiative Study","author":"Gunter","year":"2006"},{"key":"10.1016\/j.nicl.2013.12.012_bb0275","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1023\/A:1012487302797","article-title":"Cancer classification using support vector machines","author":"Guyon","year":"2002","journal-title":"Mach. Learn."},{"key":"10.1016\/j.nicl.2013.12.012_bb0145","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.mp.4001473","article-title":"Value of CSF beta-amyloid1-42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment","volume":"9","author":"Hampel","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nicl.2013.12.012_bb0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00002093-200110000-00002","article-title":"Annual incidence of Alzheimer disease in the United States projected to the years 2000 through 2050","volume":"15","author":"Hebert","year":"2001","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.nicl.2013.12.012_bb0020","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1212\/WNL.49.3.786","article-title":"Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease","volume":"49","author":"Jack","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2013.12.012_bb0015","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1212\/WNL.51.4.993","article-title":"Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease","volume":"51","author":"Jack","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2013.12.012_bb0010","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1212\/WNL.55.4.484","article-title":"Rates of hippocampal atrophy correlate with change in clinical status in aging and AD","volume":"55","author":"Jack","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2013.12.012_bb0200","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jmri.21049","article-title":"The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods","volume":"27","author":"Jack","year":"2008","journal-title":"J. Magn. Reson. Imaging"},{"key":"10.1016\/j.nicl.2013.12.012_bb0280","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awq277","article-title":"Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease","volume":"133","author":"Jack","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2013.12.012_bb0285","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","article-title":"Brain beta-amyloid load approaches a plateau","volume":"80","author":"Jack","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2013.12.012_bb0320","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/archneur.63.5.674","article-title":"Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia","volume":"63","author":"Jicha","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nicl.2013.12.012_bb0210","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.neuroimage.2005.09.046","article-title":"Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data","volume":"30","author":"Jovicich","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2013.12.012_bb0175","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.neurobiolaging.2010.04.022","article-title":"Boosting power for clinical trials using classifiers based on multiple biomarkers","volume":"31","author":"Kohannim","year":"2010","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2013.12.012_bb0195","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuroimage.2005.12.013","article-title":"Longitudinal stability of MRI for mapping brain change using tensor-based morphometry","volume":"31","author":"Leow","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2013.12.012_bb0140","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jama.2009.1064","article-title":"CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment","volume":"302","author":"Mattsson","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.nicl.2013.12.012_bb0220","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1098\/rstb.2001.0915","article-title":"A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM)","volume":"356","author":"Mazziotta","year":"2001","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.nicl.2013.12.012_bb0240","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neuroimage.2008.07.003","article-title":"Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls","volume":"43","author":"Morra","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2013.12.012_bb0245","first-page":"194","article-title":"Automatic subcortical segmentation using a contextual model","volume":"11","author":"Morra","year":"2008","journal-title":"Med. Image Comput. Comput. Assist. Interv."},{"key":"10.1016\/j.nicl.2013.12.012_bb0250","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.neuroimage.2008.10.043","article-title":"Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls","volume":"45","author":"Morra","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2013.12.012_bb0235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1109\/TMI.2009.2021941","article-title":"Comparison of adaboost and support vector machines for detecting Alzheimer's disease through automated hippocampal segmentation","volume":"29","author":"Morra","year":"2009","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.nicl.2013.12.012_bb0050","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1212\/01.WNL.0000106463.66966.65","article-title":"Delayed recall, hippocampal volume and Alzheimer neuropathology: findings from the Nun Study","volume":"62","author":"Mortimer","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2013.12.012_bb0305","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/hipo.20614","article-title":"Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields","volume":"19","author":"Mueller","year":"2009","journal-title":"Hippocampus"},{"key":"10.1016\/j.nicl.2013.12.012_bb0190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","article-title":"Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization","volume":"74","author":"Petersen","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2013.12.012_bb0120","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/archneur.59.11.1729","article-title":"Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment","volume":"59","author":"Riemenschneider","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nicl.2013.12.012_bb0065","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neurobiolaging.2003.09.009","article-title":"Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology","volume":"25","author":"Schonheit","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2013.12.012_bb0150","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21610","article-title":"Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects","volume":"65","author":"Shaw","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nicl.2013.12.012_bb0215","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1109\/42.668698","article-title":"A nonparametric method for automatic correction of intensity nonuniformity in MRI data","volume":"17","author":"Sled","year":"1998","journal-title":"IEEE Trans. Med. Imaging"},{"key":"10.1016\/j.nicl.2013.12.012_bb0265","series-title":"The Nature of Statistical Learning Theory","author":"Vapnik","year":"1995"},{"key":"10.1016\/j.nicl.2013.12.012_bb0310","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1212\/WNL.0b013e3181af79fb","article-title":"MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change","volume":"73","author":"Vemuri","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2013.12.012_bb0315","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1212\/WNL.0b013e3181af79e5","article-title":"MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations","volume":"73","author":"Vemuri","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.nicl.2013.12.012_bb0160","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.neurobiolaging.2011.12.017","article-title":"Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI","volume":"33","author":"Vos","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2013.12.012_bb0185","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3174\/ajnr.A1809","article-title":"Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease","volume":"31","author":"Walhovd","year":"2010","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.nicl.2013.12.012_bb0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000090631","article-title":"CSF biomarkers for Alzheimer's disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival","volume":"21","author":"Wallin","year":"2006","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.nicl.2013.12.012_bb0180","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.neuroimage.2012.04.056","article-title":"Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion","volume":"62","author":"Westman","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2013.12.012_bb0070","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/ana.20503","article-title":"Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia","volume":"57","author":"Zarow","year":"2005","journal-title":"Ann. Neurol."}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221315821300171X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221315821300171X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T03:57:24Z","timestamp":1761969444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221315821300171X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":63,"alternative-id":["S221315821300171X"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2013.12.012","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2013.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}